396 related articles for article (PubMed ID: 26670721)
1. Atypical defects resulting in growth hormone insensitivity.
Wit JM; de Luca F
Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
[TBL] [Abstract][Full Text] [Related]
2. A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation.
Mul D; Wu S; de Paus RA; Oostdijk W; Lankester AC; Duyvenvoorde HA; Ruivenkamp CA; Losekoot M; Tol MJ; De Luca F; van de Vosse E; Wit JM
Eur J Endocrinol; 2012 Apr; 166(4):743-52. PubMed ID: 22214923
[TBL] [Abstract][Full Text] [Related]
3. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
[TBL] [Abstract][Full Text] [Related]
4. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
[TBL] [Abstract][Full Text] [Related]
5. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone signaling in fibroblasts from newborn boys and prepubertal boys.
Ocaranza P; Morales F; Matamala Á; Gaete X; Román R; Lammoglia JJ; Cassorla F
Growth Horm IGF Res; 2016 Apr; 27():18-27. PubMed ID: 26843474
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of insulin-like growth factor deficiency.
Wit JM; Oostdijk W; Losekoot M
Endocr Dev; 2012; 23():30-41. PubMed ID: 23182818
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
Hinrichs A; Kessler B; Kurome M; Blutke A; Kemter E; Bernau M; Scholz AM; Rathkolb B; Renner S; Bultmann S; Leonhardt H; de Angelis MH; Nagashima H; Hoeflich A; Blum WF; Bidlingmaier M; Wanke R; Dahlhoff M; Wolf E
Mol Metab; 2018 May; 11():113-128. PubMed ID: 29678421
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation.
Wu S; Walenkamp MJ; Lankester A; Bidlingmaier M; Wit JM; De Luca F
J Clin Endocrinol Metab; 2010 Mar; 95(3):1220-8. PubMed ID: 20080849
[TBL] [Abstract][Full Text] [Related]
11. Genetic defects of the growth-hormone-IGF axis associated with growth hormone insensitivity.
Woods K
Endocr Dev; 2007; 11():6-15. PubMed ID: 17986822
[TBL] [Abstract][Full Text] [Related]
12. [New molecular mechanisms of growth hormone insensitivity].
Edouard T; Raynal P; Yart A; Conte-Auriol F; Salles JP; Tauber M
Arch Pediatr; 2008 Feb; 15(2):179-88. PubMed ID: 18207712
[TBL] [Abstract][Full Text] [Related]
13. Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children.
Ugarte F; Irarrazabal C; Oh J; Dettmar A; Ceballos ML; Rojo A; Ibacache MJ; Suazo C; Lozano M; Delgado I; Cavada G; Azocar M; Delucchi A; Cano F
Pediatr Nephrol; 2016 Jun; 31(6):965-74. PubMed ID: 26747624
[TBL] [Abstract][Full Text] [Related]
14. STAT5B deficiency: Impacts on human growth and immunity.
Hwa V
Growth Horm IGF Res; 2016 Jun; 28():16-20. PubMed ID: 26703237
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical manifestations and genetic mutations in a child with Laron syndrome].
Chang GY; Chen SK; Gu XF; Gong ZW; Zhang QG
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):930-3. PubMed ID: 24495765
[TBL] [Abstract][Full Text] [Related]
16. A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling.
Derr MA; Fang P; Sinha SK; Ten S; Hwa V; Rosenfeld RG
Horm Res Paediatr; 2011; 75(3):187-99. PubMed ID: 20962506
[TBL] [Abstract][Full Text] [Related]
17. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
18. Growth Hormone Receptor Mutations Related to Individual Dwarfism.
Lin S; Li C; Li C; Zhang X
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29748515
[TBL] [Abstract][Full Text] [Related]
19. A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling.
Tiulpakov A; Rubtsov P; Dedov I; Peterkova V; Bezlepkina O; Chrousos GP; Hochberg Z
J Clin Endocrinol Metab; 2005 Jan; 90(1):542-7. PubMed ID: 15536163
[TBL] [Abstract][Full Text] [Related]
20. Genetic disorders of GH action pathway.
Domené HM; Fierro-Carrión G
Growth Horm IGF Res; 2018 Feb; 38():19-23. PubMed ID: 29249625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
